Efficacy of topical Miltefosine formulations in an experimental model of cutaneous leishmaniasis

[1] Sun M(1977)Solvent effects on the fluorescent states of indole derivatives-dipole moments Photochem Photobiol 25 3-9

[2] Song PS(2004)Changing epidemiology of American cutaneous leishmaniasis (ACL) in Brazil: a disease of the urban-rural interface Acta Trop 90 155-162

[3] Oliveira CCG(2015)El inexorable avance de la Leishmaniasis: comunicación del primer caso autóctono de la Provincia de Córdoba Rev Salud Pública. 19 15-23

[4] Lacerda HG(2004)Leishmaniasis: current situation and new perspectives Comp Immunol Microbiol Infect Dis England 27 305-318

[5] Martins DRM(2018)Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia BMC Public Health 18 185-158

[6] Barbosa JDA(2019)Leishmaniasis patients’ pilgrimage to access health care in rural Bolivia: a qualitative study using human rights to health approach BMC Int Health Hum Rights 19 12-462

[7] Monteiro GR(2007)Cutaneous leishmaniasis treatment Travel Med Infect Dis Netherlands 5 150-370

[8] Queiroz JW(2012)Formulation, pharmacokinetics and pharmacodynamics of topical microbicides Best Pract Res Clin Obstet Gynaecol 26 451-160

[9] Pizzi HL(2000)Cutaneous leishmaniasis Clin Exp Dermatol Wiley Online Library 25 363-16

[10] Tómas AF(2004)Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis 91 153-51

[1] Sun M(1977)Solvent effects on the fluorescent states of indole derivatives-dipole moments Photochem Photobiol 25 3-9

[2] Song PS(2004)Changing epidemiology of American cutaneous leishmaniasis (ACL) in Brazil: a disease of the urban-rural interface Acta Trop 90 155-162

[3] Oliveira CCG(2015)El inexorable avance de la Leishmaniasis: comunicación del primer caso autóctono de la Provincia de Córdoba Rev Salud Pública. 19 15-23

[4] Lacerda HG(2004)Leishmaniasis: current situation and new perspectives Comp Immunol Microbiol Infect Dis England 27 305-318

[5] Martins DRM(2018)Comprehensive economic evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Colombia BMC Public Health 18 185-158

[6] Barbosa JDA(2019)Leishmaniasis patients’ pilgrimage to access health care in rural Bolivia: a qualitative study using human rights to health approach BMC Int Health Hum Rights 19 12-462

[7] Monteiro GR(2007)Cutaneous leishmaniasis treatment Travel Med Infect Dis Netherlands 5 150-370

[8] Queiroz JW(2012)Formulation, pharmacokinetics and pharmacodynamics of topical microbicides Best Pract Res Clin Obstet Gynaecol 26 451-160

[9] Pizzi HL(2000)Cutaneous leishmaniasis Clin Exp Dermatol Wiley Online Library 25 363-16

[10] Tómas AF(2004)Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis 91 153-51